RecruitingPhase 2NCT07297797

Phase II Clinical Study of HRS-9563 in Patients With Mild to Moderate Hypertension

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of HRS-9563 in Patients With Mild to Moderate Hypertension


Sponsor

Fujian Shengdi Pharmaceutical Co., Ltd.

Enrollment

234 participants

Start Date

Jan 14, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to evaluate the efficacy and safety of HRS-9563 in patients with mild to moderate hypertension, and to explore its appropriate dosage.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This study tests a new blood pressure medication called HRS-9563 in adults with mild to moderate high blood pressure to evaluate how safe and effective it is. **You may be eligible if...** - You are between 18 and 75 years old - You have been diagnosed with mild to moderate high blood pressure - Your average sitting systolic blood pressure (the top number) is above 130 mmHg - You meet the study's blood pressure measurement criteria at both screening and the start of the study **You may NOT be eligible if...** - You have severe high blood pressure or a secondary cause for your blood pressure (such as kidney disease) - You are currently taking blood pressure medications that cannot be safely stopped - You have significant heart, kidney, or liver problems - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGHRS-9563 Injection

HRS-9563 Injection

DRUGsodium chloride injection

sodium chloride injection


Locations(1)

Beijing Anzhen Hospital, Capital Medical University

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07297797


Related Trials